Emetrol Powder
- Product NDC
- 65197-203
- 11-digit product format
- 651970203
- Labeler code
- 65197
- Product ID
- 65197-203_a6121b17-e850-4677-9ad1-ceb36de16336
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sodium Citrate Dihydrate
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- WellSpring Pharmaceutical Corporation
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2023-12-01
- Substance
- TRISODIUM CITRATE DIHYDRATE
- Active strength
- 460 mg/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Emetrol Powder
- Brand name suffix
- Non-Drowsy
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TRISODIUM CITRATE DIHYDRATE | 460 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B22547B95K |
| Rxcui | 2671573, 2671579 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65197-203-09 | Emetrol PowderNon-Drowsy | 6 in 1 CARTON | POWDER, FOR SOLUTION | 6 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65197-203 | EMETROL POWDER NON-DROWSY (SODIUM CITRATE DIHYDRATE) POWDER, FOR SOLUTION [WELLSPRING PHARMACEUTICAL CORPORATION] | 3 | Current NDC, 1 package rows | 20250110_9d8d2ee7-9db7-4be7-8c73-511eb2e32459.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 65197-203-09 | 65197020309 | 6 POWDER, FOR SOLUTION in 1 CARTON (65197-203-09) | 2023-12-01 | No | No | Current |